This topic introduces the embryological origins and developmental processes of bones, muscles, joints, and connective tissues, laying the foundation for understanding congenital conditions. Learning Objective: Describe the key stages in the embryonic development of the musculoskeletal system and identify common developmental abnormalities.

This section examines how muscles contract, how bones remodel, and how movement is coordinated physiologically at cellular and systemic levels. Learning Objective: Explain the physiological mechanisms underlying muscle contraction, bone remodeling, and coordinated movement.

Learners study disorders affecting muscles, bones, and joints, including degenerative, inflammatory, metabolic, infectious, and neoplastic conditions. Learning Objective: Recognize common musculoskeletal diseases and explain the underlying pathological mechanisms.

This topic covers the major drugs used in musculoskeletal conditions, including bone-active agents, anti-inflammatories, DMARDs, and muscle relaxants. Learning Objective: Describe key pharmacological agents used to treat musculoskeletal disorders and explain their mechanisms of action.

tudents learn systematic approaches to examining the musculoskeletal system, including inspection, palpation, range of motion testing, strength assessment, and special tests. Learning Objective: Perform a structured musculoskeletal examination and interpret clinical findings